ZBIO logo

ZBIO
Zenas Biopharma Inc.

804
Mkt Cap
$1.17B
Volume
384,653.00
52W High
$44.60
52W Low
$7.34
PE Ratio
-2.42
ZBIO Fundamentals
Price
$20.44
Prev Close
$21.28
Open
$21.28
50D MA
$23.14
Beta
1.43
Avg. Volume
806,748.53
EPS (Annual)
-$8.44
P/B
4.60
Rev/Employee
$59,880.24
$1,360.92
Loading...
Loading...
News
all
press releases
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Fairmount Funds Management Llc Acquires 150,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Fairmount Funds Management Llc purchased 150,000 shares of the stock in a transaction on Tuesday, March 31st. The stock was acquired at...
MarketBeat·9d ago
News Placeholder
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Hongbo Lu purchased 3,768 shares of Zenas BioPharma stock in a transaction dated Tuesday, March 31st. The stock was bought at an average price of $18.63 per share, with a total value of $70,197.84. Following the completion of the...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% Following Insider Buying Activity
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% After Insider Buying Activity...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Director Purchases $3,000,000.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Fairmount Funds Management Llc acquired 150,000 shares of the stock in a transaction dated Tuesday, March 31st. The stock was acquired at an average cost of $20.00 per share, for a total transaction of $3,000,000.00. Following the...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma Stock Falls 20% After Pricing $300 Mln Offerings
(RTTNews) - Stock of Zenas BioPharma, Inc. (ZBIO) is moving down about 20 percent on Friday morning trading after the company announced the pricing of concurrent public offerings of $200 million in convertible senior notes due 2032 and $100 million in common stock, for total gros...
Nasdaq News: Markets·15d ago
News Placeholder
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.read more...
Benzinga·16d ago
News Placeholder
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Recommendation of "Hold" from Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) has received a consensus recommendation of "Hold" from the nine research firms that are currently covering the company, MarketBeat.com reports...
MarketBeat·17d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.5% - Should You Sell?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7.5% - Here's Why...
MarketBeat·19d ago
News Placeholder
ENAVATE's Zenas Bio Pharma add Is a Footnote The Obexelimab Pipeline Is What to Watch
Key PointsENAVATE Added 157,800 shares of Zenas BioPharma worth an estimated $5.19 million (based on quarterly average price...
Nasdaq News: Markets·21d ago
<
1
2
...
>

Latest ZBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.